Pub. Date : 2016 Mar
PMID : 27030119
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Clinical trials and meta-analyses have also demonstrated that patients treated with exenatide and, to a larger extent, with liraglutide are significantly more likely to achieve the composite endpoint of glycated hemoglobin <7%, no hypoglycemia and no weight gain as compared to patients exposed to other diabetes treatment, including dipeptidyl peptidase-4 inhibitors and insulin glargine. | Exenatide | dipeptidyl peptidase 4 | Homo sapiens |